Crossmark

Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase–negative cells

Crossref DOI link: https://doi.org/10.1007/s00432-020-03213-x

Published Online: 2020-04-24

Published Print: 2020-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zencir, Sevil

Hsieh, Meng-Hsun

Hsu, Joel-Sean

Ergun, Yavuz

Chou, Guan-Ling

Li, Tsai-Kun

Teng, Shu-Chun

Topcu, Zeki
License Information

Text and Data Mining valid from 2020-04-24

Version of Record valid from 2020-04-24
More Information

Article History

Received: 6 January 2020

Accepted: 7 April 2020

First Online: 24 April 2020

Compliance with ethical standards

:

: The authors declare no competing financial and non-financial interests.

Document is current

Any future updates will be listed below